Theolytics Ltd.. (4/17/24). "Press Release: Theolytics Successfully Closes Latest Financing Raising Total of £19M ($24.5M) and Welcomes Sound Bioventures as New Investor". Oxford. |
2024-04-17 |
Domain Therapeutics S.A.. (4/17/24). "Press Release: Domain Therapeutics Appoints Sean A. MacDonald as Chief Executive Officer". Strasbourg, Motnreal, QC & Boston, MA. |
2024-04-17 |
NanoString Technologies, Inc.. (4/17/24). "Press Release: NanoString Technologies to Be Acquired by Bruker Corporation. Bruker Wins Competitive Auction". Seattle, WA. |
2024-04-17 |
MedinCell S.A.. (4/16/24). "Press Release: Medincell Enters into Strategic Co-development and Licensing Agreement with AbbVie to Develop Next-generation Long-acting Injectable Therapies". Montpellier. |
2024-04-16 |
Naobios. (4/15/24). "Press Release: Naobios and Sumagen Sign Exclusive Partnership to Develop HIV Vaccine". Nantes. |
2024-04-15 |
Roche. (4/11/24). "Press Release: Roche Granted FDA Breakthrough Device Designation for Blood Test to Support Earlier Alzheimer's Disease Diagnosis". Basel. |
2024-04-11 |
FundaMental Pharma GmbH. (4/11/24). "Press Release: FundaMental Pharma Appoints Dr. Dirk Beher as Chief Executive Officer". Heidelberg. |
2024-04-11 |
Asahi Kasei Bioprocess. (4/11/24). "Press Release: Asahi Kasei Bioprocess and Axolabs Announce Strategic Partnership to Accelerate Oligonucleotide Therapeutics Development". Düsseldorf, Tokyo & New York, NY. |
2024-04-11 |
CRS Clinical Research Services Management GmbH. (4/10/24). "Press Release: CRS Appoints Catherine Canales as New Chief Commercial Officer to Fuel Strategic Development and International Growth". Mannheim. |
2024-04-10 |
Seaport Therapeutics. (4/9/24). "Press Release: Seaport Therapeutics Launches with $100 Million Oversubscribed Series A Financing Round to Advance Novel Neuropsychiatric Medicines". Boston, MA. |
2024-04-09 |
Boehringer Ingelheim. (4/9/24). "Press Release: Boehringer Ingelheim Biopharmaceuticals China Receives Approval for Supply of EU and US Markets". Ingelheim & Shanghai. |
2024-04-09 |
Pantherna Therapeutics GmbH / Wacker. (4/5/24). "Press Release: Pantherna and Wacker Intensify Collaboration in the Development and Production of mRNA Biopharmaceuticals". Munich & Hennigsdorf. |
2024-04-05 |
Basilea Pharmaceutica Ltd.. (4/4/24). "Press Release: Basilea Announces US FDA Approval of Antibiotic Zevtara (ceftobiprole medocaril) for Three Indications". Allschwil. |
2024-04-04 |
Caris Life Sciences Inc.. (4/4/24). "Press Release: Caris Life Sciences Announces Partnership with Merck KGaA, Darmstadt, Germany to Discover Novel Cancer Targets and Accelerate First-In-Class Antibody Drug Conjugate Development". Irving, TX. |
2024-04-04 |
Biognosys AG. (4/4/24). "Press Release: Biognosys and Alamar Biosciences Forge Strategic Partnership in Proteomics to Advance Biopharma and Precision Medicine Research". Zürich & Fremont, CA. |
2024-04-04 |
EnteroBiotix Ltd.. (4/4/24). "Press Release: EnteroBiotix Completes £27m Financing Round to Advance Clinical Trials". Glasgow. |
2024-04-04 |
Addex Therapeutics S.A.. (4/3/24). "Press Release: Addex and Perceptive Launch Neurosterix with $63 Million to Accelerate Development of Allosteric Modulator Therapeutics for Neurological Disorders". Geneva & New York, NY. |
2024-04-03 |
HealthTech For Care. (4/3/24). "Press Release: HealthTech For Care Launches Its European Patient Observatory to Accelerate Healthcare Equality in Europe". Paris. |
2024-04-03 |
EnteroBiotix Ltd.. (4/3/24). "Press Release: EnteroBiotix Initiates Phase 2 Study of EBX-102-02 in Patients with Irritable Bowel Syndrome (IBS)". Glasgow. |
2024-04-03 |
Alterome Therapeutics, Inc.. (4/3/24). "Press Release: Alterome Therapeutics Raises $132 Million in Series B Financing Led by Goldman Sachs Alternatives". San Diego, CA. |
2024-04-03 |
Genmab A/S. (4/3/24). "Press Release: Genmab to Broaden and Strengthen Oncology Portfolio with Acquisition of ProfoundBio". Copenhagen & Seattle, WA. |
2024-04-03 |
BioGeneration Ventures B.V.. (4/2/24). "Press Release: BGV Appoints Peter Halle, PhD as Venture Partner". Amsterdam. |
2024-04-02 |
Sparxell UK Ltd.. (4/2/24). "Press Release: Sparxell Raises $3.2m to Advance Development of Sustainable Pigments". Cambridge. |
2024-04-02 |
Protembis GmbH. (4/2/24). "Press Release: Protembis Announces First Patient Enrolled in the PROTEMBO IDE Pivotal Trial". New York, NY & Aachen. |
2024-04-02 |
Lonza Group AG. (4/2/24). "Press Release: Wolfgang Wienand, Currently CEO of Swiss CDMO Siegfried Holding AG, Will Become Chief Executive Officer of Lonza in the Summer of 2024". Basel. |
2024-04-02 |
Ipsen S.A.. (4/2/24). "Press Release: Ipsen and Sutro Biopharma Announce Exclusive Global Licensing Agreement for an ADC Targeting solid tumors". Paris & San Francisco, CA. |
2024-04-02 |
Merz Asset Management Holding GmbH & Co. KG. (4/2/24). "Press Release: Merz Enters Asset Purchase Agreement with a US-based Biotech Company". Frankfurt am Main. |
2024-04-02 |
NewAmsterdam Pharma Company N.V.. (4/1/24). "Press Release: NewAmsterdam Pharma Announces the Appointment of Juliette Audet as Chief Business Officer". Naarden & Miami, FL. |
2024-04-01 |
TGZ Halle Technologie- und Gründerzentrum Halle GmbH. (3/28/24). "Pressemitteilung: Minister Schulze übergibt Fördermittelbescheid für Neubau am Weinberg Campus. Förderung in Höhe von 14,7 Millionen Euro für neues Innovations- und Gründerzentrum in Halle |
2024-03-28 |
SurgeCare SAS. (3/27/24). "Press Release: Surge Announces Closing of a €7.5 Million Fundraising Round to Decrypt the Immune System and Transform Precision Medicine". Paris. |
2024-03-27 |
Venturelab AG. (3/27/24). "Press Release: Venture Leaders Biotech 2024 – 10 Innovative Startups Selected for the Boston Roadshow". |
2024-03-27 |
Innocent Meat GmbH. (3/26/24). "Press Release: Innocent Meat Raised EUR 3 Million". |
2024-03-26 |
CMS Hasche Sigle. (3/26/24). "Press Release: CMS Advises Sellers of Cardior Pharmaceuticals on Potential Acquisition by Novo Nordisk". Munich. |
2024-03-26 |
ERS Genomics Ltd.. (3/26/24). "Press Release: Key Charpentier/Doudna CRISPR Patent Upheld by China National Intellectual Property Administration". Dublin. |
2024-03-26 |
Protembis GmbH. (3/26/24). "Press Release: Protembis Announces Completion of € 30 Million Series B Financing Round and the Addition of Keith D Dawkins MD to the Board of Directors". Aachen. |
2024-03-26 |
Cardior Pharmaceuticals GmbH. (3/25/24). "Press Release: Novo Nordisk to Acquire Cardior Pharmaceuticals and Strengthen Pipeline in Cardiovascular Disease". Bagsværd & Hannover. |
2024-03-25 |
Volumina Medical SA. (3/25/24). "Press Release: Volumina Medical Secures USD 21 Million Funding to Continue Its Clinical Program after Having Obtained Promising First in Human Data". Epalinges. |
2024-03-25 |
Kranus Health GmbH. (3/25/24). "Press Release: Kranus Health Increases Funding to USD 20 Million Total, Cementing Its Position as a Leader in Virtual Care in Urology". Berlin, Munich & Paris. |
2024-03-25 |
Hemotune AG. (3/25/24). "Press Release: Hemotune Raises CHF 14 Million Series B2 Funding for Clinical Trials with the HemoSystem". Schlieren. |
2024-03-25 |
OpGen, Inc.. (3/25/24). "Press Release: OpGen Announces Acquisition of Preferred Stock by David Lazar". Rockville, MD. |
2024-03-25 |
Tricares SAS. (3/25/24). "Press Release: Tricares Announces the Appointment of Ahmed Elmouelhi as President & Chief Executive Officer". Paris & Munich. |
2024-03-25 |
TNO. (3/25/24). "Press Release: TNO Launches Peregrion to Boost Market Impact of Its Technology that Accelerates Medicine Development". Leiden. |
2024-03-25 |
Angelini Ventures S.p.A.. (3/21/24). "Press Release: Angelini Ventures Invests into Extended €75.8 Million ($82 Mmillion) Series C Financing Round for Nouscom". Rome. |
2024-03-21 |
Eisbach Bio GmbH. (3/21/24). "Press Release: Eisbach and Cancer Focus Fund Announce $4.5 Million Investment to Support First-in-Human Phase 1/2 Trial of EIS-12656 for Refractory Advanced Solid Tumors". Martinsried & Houston, TX. |
2024-03-21 |
Mirador Therapeutics, Inc.. (3/21/24). "Press Release: Mirador Therapeutics Launches to Accelerate the Next Generation of Precision Medicines for Immune-mediated Diseases". San Diego, CA. |
2024-03-21 |
Owkin. (3/21/24). "Press Release: Owkin Expands Collaboration with Sanofi Leveraging AI for Drug Positioning in immunology". |
2024-03-21 |
Cure51 SAS. (3/20/24). "Press Release: Cure51 Raises a €15 Million Seed Round to Harness the Natural Power of Cancer Survivors to Develop First-in-Class Treatments and Transform Cancer into a Curable Disease". Paris. |
2024-03-20 |
Capstan Therapeutics, Inc.. (3/20/24). "Press Release: Capstan Therapeutics Announces $175M Oversubscribed Series B Financing". San Diego, CA. |
2024-03-20 |
Lonza Group AG. (3/20/24). "Press Release: Lonza Signs Agreement to Acquire Large-scale Biologics Site in Vacaville (US) from Roche". Basel. |
2024-03-20 |
Climedo Health GmbH. (3/20/24). "Press Release: Climedo Establishes Advisory Board to Enter its Next Growth Chapter". Munich. |
2024-03-20 |
Idorsia Ltd.. (3/20/24). "Press Release: US FDA Approves Idorsia’s Once-daily Tryvio (aprocitentan) – the First and Only Endothelin Receptor Antagonist for the Treatment of High Blood Pressure Not Adequately Controlled in Combination with other Antihyper |
2024-03-20 |
BioNTech SE. (3/20/24). "Press Release: BioNTech Announces Appointment of Annemarie Hanekamp to Management Board as Chief Commercial Officer". Mainz. |
2024-03-20 |
Engrail Therapeutics, Inc.. (3/19/24). "Press Release: Engrail Therapeutics Closes Oversubscribed $157M Series B Financing Round to Advance the Development of Transformational Therapies". San Diego, CA. |
2024-03-19 |
Medios AG. (3/18/24). "Press Release: Medios Acquires Dutch Market Leader in Pharmaceutical Compounding Services". Berlin. |
2024-03-18 |
Idorsia Ltd.. (3/18/24). "Press Release: Idorsia and Viatris Successfully Close the Transaction for the Global Research and Development Collaboration". Allschwil. |
2024-03-18 |
Bico Group AB. (3/15/24). "Press Release: Founders Leave after Eight Years". |
2024-03-15 |
Tubulis GmbH. (3/14/24). "Press Release: Tubulis Closes Upsized €128 Million Series B2 to Accelerate Clinical Development of Solid Tumor-Focused ADC Pipeline". Munich. |
2024-03-14 |
Nuclera Ltd.. (3/14/24). "Press Release: Nuclera Appoints Joseph Bertelsen as Chief Commercial Officer". Cambridge. |
2024-03-14 |
Asgard Therapeutics AB. (3/14/24). "Press Release: Asgard Therapeutics Announces €30 Million Series A Financing to Advance Its First-in-Class in vivo Cell Reprogramming Platform for Immuno-oncology". Lund. |
2024-03-14 |
IMBA – Institute of Molecular Biotechnology GmbH. (3/14/24). "Press Release: Elly Tanaka – IMBA’s New Scientific Director". |
2024-03-14 |
Alithea Genomics S.A.. (3/14/24). "Press Release: Alithea Genomics Closes CHF 2.8 Million in Seed Financing Extension Led by Novalis Biotech". Lausanne. |
2024-03-14 |
Relation Therapeutics Ltd.. (3/14/24). "Press Release: Relation Therapeutics Secures $35 Million of New Seed Financing Led by DCVC and Co-lead NVentures, Nvidia’s Venture Arm". London. |
2024-03-14 |
Amolyt Pharma SAS. (3/14/24). "Press Release: Amolyt Pharma Enters into Definitive Agreement to be Acquired by AstraZeneca. AstraZeneca Will Acquire Amolyt Pharma for up to $1.05 Billion in Total Consideration". Lyon & Cambridge, MA. |
2024-03-14 |
Aignostics GmbH. (3/14/24). "Press Release: Bayer and Aignostics to Collaborate on Next Generation Precision Oncology". |
2024-03-14 |
ERS Genomics Ltd.. (3/13/24). "Press Release: Ricoh and ERS Genomics Enter into CRISPR/Cas9 License Agreement". Tokyo & Dublin. |
2024-03-13 |
ProBioGen AG. (3/13/24). "Press Release: ProBioGen Partners with Mapp Biopharmaceutical, Inc. for Groundbreaking Development of Afucosylated Antibody against Marburg Virus Disease Using GlymaxX Technology". Berlin. |
2024-03-13 |
ProteoNic Biosciences B.V.. (3/13/23). "Press Release: ProteoNic Announces Partnership with Ginkgo Bioworks and Joins the Ginkgo Technology Network". |
2024-03-13 |
Fida Biosystems ApS. (3/13/24). "Press Release: In-Solution Kinetics by Fida Biosystems – Redefining Drug Interaction Analysis for Therapeutic Discovery". Copenhagen. |
2024-03-13 |
Mahana Therapeutics Inc.. (3/12/24). "Press Release: Mahana Therapeutics Acquires Cara Care to Become a Global Leader in the Digital Treatment of Chronic Conditions". San Francisco, CA. |
2024-03-12 |
Poltreg S.A.. (3/11/24). "Press Release: Poltreg’s State-of-the-Art Manufacturing Facility Has Received Approval to Produce Cellular Therapies from the Chief Pharmaceutical Inspectorate in Poland". |
2024-03-11 |
Sosei Group Corporation (d/b/a Sosei Heptares). (3/11/24). "Press Release: Boehringer Ingelheim and Sosei Heptares Join Forces to Develop First-in-class Treatments Targeting All Symptoms of Schizophrenia". Ingelheim, Tokyo & Cambridge. |
2024-03-11 |
Praque.bio, z.s.. (3/11/24). "Press Release: This Fall Prague Will Be the Stage for a Showcase of Cutting-edge Biotechnologies Featuring Prominent Figures such as Christian A. Stein, Petr Jansa, and other Leading Experts". Prague. |
2024-03-11 |
NanoString Technologies, Inc.. (3/10/24). "Press Release: Patient Square Capital, a Leading Health Care-Focused Investment Firm, Agrees to Acquire NanoString Technologies". Seattle, WA. |
2024-03-10 |
IZB Martinsried. (3/8/24). "Press Release: Christian Gnam Succeeds Dr. Peter Zobel as New Managing Director of the Biotechnology Innovation and Start-up Center (IZB)". Martinsried. |
2024-03-08 |
ProteinDistillery GmbH. (3/7/24). "Press Release: ProteinDistillery Raises €15 Million in Seed Funding". Esslingen & Berlin. |
2024-03-07 |
Affimed N.V.. (3/6/24). "Press Release: Affimed Announces 1-for-10 Reverse Stock Split". Mannheim. |
2024-03-06 |
Tubulis GmbH. (3/5/24). "Press Release: Tubulis to Present Preclinical Proof-of-Concept Data for Two Lead ADC Candidates Targeting Solid Tumors at the AACR Annual Meeting 2024". Munich. |
2024-03-05 |
Invivo Partners. (3/5/24). "Press Release: Invivo Partners Is Preparing to Launch a €100M Invivo Ventures III Fund to Invest in Leading-edge Life Sciences". Barcelona. |
2024-03-05 |
C4 Therapeutics, Inc.. (3/4/24). "Press Release: C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Germany, Against Critical Oncogenic Proteins". Watertown, MA. |
2024-03-04 |
Precisio Biotix Therapeutics, Inc.. (3/1/24). "Press Release: Precisio Biotix Therapeutics Acquires London-headquartered CC Bio, Adding World-class Antibacterial Platform and Top Scientists". Dover, DE. |
2024-03-01 |
Pierre Fabre. (3/1/24). "Press Release: Kinnate Biopharma Inc. Sells Its Investigational Pan-RAF Inhibitor, Exarafenib, to Pierre Fabre Laboratories". San Francisco, CA & Castres. |
2024-03-01 |
BRAIN Biotech AG. (2/29/24). "Press Release: BRAIN Biotech AG Successfully Placed EUR 5.0 Million Convertible Bond for the Financing of Further Growth Initiatives [Not for US, AU, et al.]". Zwingenberg. |
2024-02-29 |
Symrise AG. (2/29/24). "Press Release: Dr Jean-Yves Parisot Assumes CEO Position from Dr Heinz-Jürgen Bertram". Holzminden. |
2024-02-29 |
Gedea Biotech AB. (2/29/24). "Press Release: The Swedish Femtech Company Gedea Biotech Selected for Prestigious Grant Funding from the European Innovation Council, EIC". |
2024-02-29 |
Precirix N.V.. (2/29/24). "Press Release: Tom Plitz Commences Role as Chief Executive Officer of Precirix". Brussels. |
2024-02-29 |
Inpart SAS. (2/29/24). "Press Release: Inpart and Evaluate Announce Strategic Partnership to Optimize Biopharma Dealmaking". Lyon. |
2024-02-29 |
Neobe Therapeutics Ltd.. (2/29/24). "Press Release: Neobe Therapeutics Raises over $2m for Synthetic Biology Enabled Tumour Microenvironment Remodelling". |
2024-02-29 |
Centogene N.V.. (2/28/24). "Press Release: Centogene Announces Receipt of Nasdaq Notice of Delisting and Intention to Request a Hearing". Cambridge, MA, Rostock & Berlin. |
2024-02-28 |
Viatris Inc.. (2/28/24). "Press Release: Viatris Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides 2024 Financial Guidance". Pittsburgh, PA. |
2024-02-28 |
Idorsia Ltd.. (2/28/24). "Press Release: Idorsia and Viatris Enter into a Significant Global Research and Development Collaboration". Allschwil. |
2024-02-28 |
Royal Philips. (28/2/24). "Press Release: Charlotte Hanneman to Succeed Abhijit Bhattacharya as Philips’ Chief Financial Officer (CFO)". Amsterdam. |
2024-02-28 |
Centogene N.V.. (2/28/24). "Press Release: Centogene Explores Strategic Alternatives". Cambridge, MA, Rostock & Berlin. |
2024-02-28 |
Luxembourg Institute of Health (LIH). (2/27/24). "Press Release: Strategic Partnership Forges Innovation in Luxembourg HealthTech. Luxembourg Institute of Health and Catalpa Ventures Join Forces". |
2024-02-27 |
Stilla Technologies SAS. (2/22/24). "Press Release: Stilla Technologies Closes $26.5M Series C Financing to Accelerate Commercialization of Its Digital PCR Platform – Expands Leadership team". Paris & Boston, MA. |
2024-02-22 |
Ansa Biotechnologies, Inc.. (2/22/24). "Press Release: Ansa Biotechnologies Appoints Jason T. Gammack as CEO and Prepares for Launch of Rapid Enzymatic Synthesis Service for Complex DNA Sequences". Emeryville, CA. |
2024-02-22 |
InflaRx N.V.. (2/22/24). "Press Release: InflaRx Appoints Jan Medina as Head of Investor Relations". Jena. |
2024-02-22 |
Plasmion GmbH. (2/21/24). "Press Release: Plasmion and Waters Corporation Sign a Co-marketing and Co-promotion Agreement to Enhance and Simplify Chemical Analysis". Augsburg. |
2024-02-21 |
Cyclize GmbH. (2/21/24). "Press Release: ClimateTech Startup Cyclize Secures €5 Million in Seed Funding for Revolutionary Plastic Recycling Technology". Munich. |
2024-02-21 |
Agilent Technologies Inc.. (2/21/24). "Press Release: Agilent CEO Mike McMullen to Retire Agilent CrossLab Group – President Padraig McDonnell Named CEO-Elect". Santa Clara, CA. |
2024-02-21 |
Cresset Biomolecular Discovery Ltd.. (2/21/24). "Press Release: Cresset Announces Global Collaboration with Enamine on New Virtual Screening Drug Discovery Technology". Cambridge. |
2024-02-21 |